Distinct relationships between risky decision making and cocaine self-administration under short- and long-access conditions.
Choice
Cocaine
Risk taking
Self-administration
Journal
Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617
Informations de publication
Date de publication:
02 03 2020
02 03 2020
Historique:
received:
11
07
2019
revised:
01
10
2019
accepted:
16
10
2019
pubmed:
5
11
2019
medline:
23
11
2021
entrez:
3
11
2019
Statut:
ppublish
Résumé
Substance use is strongly associated with impaired decision making, with cocaine use particularly linked to elevated risky and impulsive choice. It is not clear, however, whether such maladaptive decision making is a consequence of cocaine use or instead precedes and predisposes individuals to cocaine use. The current study was designed to specifically address the latter possibility with respect to risky choice in both male and female rats. Rats were first trained in a "Risky Decision-making Task" (RDT), in which they made discrete choices between a small, "safe" food reward and a large, "risky" food reward accompanied by increasing probabilities of mild footshock punishment. After reaching stable performance, rats underwent jugular catheter surgery followed by either short-access cocaine self-administration sessions (2 h, 0.5 mg/kg/infusion) for 5 days or long-access cocaine self-administration sessions (6 h, 0.5 mg/kg/infusion) for 14 days. Under short-access conditions, there was no relationship between risk preference and changes in cocaine intake over time, but greater risk aversion in females predicted greater overall cocaine intake. Under long-access conditions, heightened risk taking predicted greater escalation of cocaine intake over the course of self-administration, supporting the notion that pre-existing risk-taking behavior predicts cocaine intake. Collectively, results from these experiments have implications for understanding and identifying pre-existing vulnerabilities to substance use, which may lead to strategies to prevent development of substance use disorders.
Identifiants
pubmed: 31676462
pii: S0278-5846(19)30578-0
doi: 10.1016/j.pnpbp.2019.109791
pmc: PMC7375467
mid: NIHMS1542470
pii:
doi:
Substances chimiques
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109791Subventions
Organisme : NIDA NIH HHS
ID : R01 DA024671
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA041493
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG061892
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA036534
Pays : United States
Organisme : NIDA NIH HHS
ID : K99 DA041493
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Neuropsychopharmacology. 2014 Mar;39(4):955-62
pubmed: 24145852
Neuropharmacology. 2018 Sep 1;139:205-216
pubmed: 30009836
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):94-103
pubmed: 28164168
Pharmacol Biochem Behav. 2002 Jul;72(4):931-6
pubmed: 12062583
Cereb Cortex. 2009 Feb;19(2):435-44
pubmed: 18539927
Exp Neurol. 2014 Sep;259:64-74
pubmed: 24508560
Brain Res. 1997 Dec 19;778(2):418-29
pubmed: 9459563
Pharmacol Biochem Behav. 2018 Jan;164:118-124
pubmed: 28927583
Front Neuroendocrinol. 2008 Jan;29(1):36-47
pubmed: 17904621
Behav Pharmacol. 2018 Dec;29(8):745-761
pubmed: 30394882
Behav Neurosci. 2014 Aug;128(4):419-29
pubmed: 24841739
Psychopharmacology (Berl). 1999 May;144(1):77-82
pubmed: 10379627
Drug Alcohol Depend. 2005 Feb 14;77(2):169-75
pubmed: 15664718
Psychopharmacology (Berl). 2015 Jul;232(13):2363-75
pubmed: 25662610
Pharmacol Biochem Behav. 2009 Sep;93(3):343-8
pubmed: 19490925
Psychopharmacology (Berl). 2005 Mar;178(2-3):193-201
pubmed: 15338104
Behav Neurosci. 2007 Apr;121(2):380-8
pubmed: 17469928
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
pubmed: 10817843
Neurosci Biobehav Rev. 2004 Jan;27(8):721-8
pubmed: 15019422
Psychopharmacology (Berl). 1999 Oct;146(3):303-12
pubmed: 10541731
Brain Res. 1986 Jun;396(2):157-98
pubmed: 3527341
Drug Alcohol Depend. 2015 Apr 1;149:166-72
pubmed: 25697912
Brain Res. 2002 Mar 15;930(1-2):12-20
pubmed: 11879790
Horm Behav. 2010 Jun;58(1):44-56
pubmed: 19818789
Neuroscience. 2018 Jan 15;369:212-221
pubmed: 29155278
Neuropsychopharmacology. 2012 May;37(6):1377-86
pubmed: 22318198
Science. 1998 Oct 9;282(5387):298-300
pubmed: 9765157
Br J Pharmacol. 2007 Nov;152(5):795-804
pubmed: 17891164
Neuropsychologia. 2001;39(4):376-89
pubmed: 11164876
Neuropsychopharmacology. 2004 Jan;29(1):81-5
pubmed: 12955098
Behav Brain Res. 2019 Feb 1;359:579-588
pubmed: 30296531
Behav Brain Res. 2013 Feb 1;238:95-108
pubmed: 23078950
J Neurosci Res. 2017 Jan 2;95(1-2):260-269
pubmed: 27870448
Neuropsychopharmacology. 2012 Nov;37(12):2605-14
pubmed: 22871910
Nat Neurosci. 2006 Aug;9(8):1050-6
pubmed: 16829955
J Neurosci. 2013 Apr 24;33(17):7501-12
pubmed: 23616555
PLoS One. 2007 Aug 01;2(8):e698
pubmed: 17668074
Nat Neurosci. 2002 Feb;5(2):169-74
pubmed: 11802171
J Gambl Stud. 2019 Mar;35(1):47-62
pubmed: 29860582
Behav Brain Res. 2008 Jan 10;186(1):48-56
pubmed: 17719099
Behav Neurosci. 2009 Feb;123(1):156-64
pubmed: 19170440
Behav Pharmacol. 2011 Dec;22(8):794-804
pubmed: 22015805
Neuropsychopharmacology. 2006 Jan;31(1):129-38
pubmed: 15920500
Behav Neurosci. 2016 Feb;130(1):50-61
pubmed: 26653713
PLoS One. 2010 Sep 22;5(9):e12835
pubmed: 20877644
Pharmacol Biochem Behav. 1999 Nov;64(3):507-12
pubmed: 10548263
Pharmacol Biochem Behav. 2004 Jun;78(2):199-207
pubmed: 15219759
J Neurosci. 2011 Nov 30;31(48):17460-70
pubmed: 22131407
Exp Clin Psychopharmacol. 2005 Nov;13(4):311-8
pubmed: 16366761
Neuropharmacology. 2007 Feb;52(2):646-54
pubmed: 17098261
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt A):3-10
pubmed: 28965843
Science. 2007 Mar 2;315(5816):1267-70
pubmed: 17332411
Exp Clin Psychopharmacol. 2006 Feb;14(1):34-41
pubmed: 16503703
Arch Gen Psychiatry. 2012 Dec;69(12):1295-303
pubmed: 23070149
Biol Sex Differ. 2011 Mar 11;2:3
pubmed: 21396095
Addict Biol. 2017 Jul;22(4):991-1001
pubmed: 27002211
Exp Clin Psychopharmacol. 2008 Apr;16(2):165-77
pubmed: 18489020
Neurobiol Learn Mem. 2015 Jan;117:60-70
pubmed: 24642448
Physiol Behav. 2019 May 1;203:18-24
pubmed: 29056351
Behav Neurosci. 2010 Aug;124(4):470-7
pubmed: 20695646
Psychopharmacology (Berl). 2017 Feb;234(3):437-446
pubmed: 27837333
Psychopharmacology (Berl). 2012 Jul;222(2):257-67
pubmed: 22249361
Neuropsychopharmacology. 2009 Sep;34(10):2208-17
pubmed: 19440192
PLoS One. 2013 Nov 18;8(11):e79465
pubmed: 24260227
Drug Alcohol Depend. 2005 Apr 4;78(1):83-90
pubmed: 15769561
Eur J Public Health. 2011 Dec;21(6):753-5
pubmed: 21071390